Screening of selected risk factors in developmental dysplasia of the hip: an observational study

Background Developmental dysplasia of the hip (DDH) is the most common neonatal musculoskeletal condition. In 2008, the NHS Newborn and Infant Physical Examination committee added selective ‘at risk’ screening to the existing universal neonatal and general practitioner clinical hip screening guideli...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood Vol. 98; no. 9; pp. 692 - 696
Main Authors: Talbot, Christopher L, Paton, Robin W
Format: Journal Article
Language:English
Published: London BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01-09-2013
BMJ Publishing Group
BMJ Publishing Group Ltd
BMJ Publishing Group LTD
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Developmental dysplasia of the hip (DDH) is the most common neonatal musculoskeletal condition. In 2008, the NHS Newborn and Infant Physical Examination committee added selective ‘at risk’ screening to the existing universal neonatal and general practitioner clinical hip screening guidelines. Objective Assessment of breech and family history risk factors in DDH. Design A 15 year prospective, observational, longitudinal cohort study. Method Breech presentation and evidence of a strong family history for DDH were the ‘risk factors’ studied. All infants referred were clinically and sonographically screened by one consultant paediatric orthopaedic surgeon. Results From a cohort of 64 670 live births, 2984 neonates/infants, 46.1 (95% CI 44.6 to 47.8) per 1000 live births, were referred and sonographically screened with these risk factors alone. 1360 were male, of which four were identified as having ‘pathological’ DDH (an incidence of 0.003 (95% CI 0.001 to 0.008)). 1624 were female, of which 45 were identified as having ‘pathological’ DDH (an incidence of 0.028 (95% CI 0.021 to 0.037)). This difference in incidence of 0.025 (95% CI 0.016 to 0.033) was statistically significant (p<0.001). From those who were clinically stable and screened with either or both of the two risk factors, four individuals were diagnosed with irreducible hip dislocation (0.06 (95% CI 0.024 to 0.159) per 1000 live births). All were females. Conclusions This study questions the current UK screening policy for DDH in clinically stable males referred with risk factors, and may influence future DDH screening programme policy.
Bibliography:PMID:23852998
ArticleID:archdischild-2013-303647
local:archdischild;98/9/692
istex:F7B13F28C6AB2C14339A3F010FE4D8262D1815B1
ark:/67375/NVC-M7KQ94XF-H
href:archdischild-98-692.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0003-9888
1468-2044
DOI:10.1136/archdischild-2013-303647